Welcome to LookChem.com Sign In|Join Free
  • or
Norathyriol is a member of the xanthone class, specifically a 9H-xanthen-9-one molecule substituted by hydroxy groups at positions 1, 3, 6, and 7. It is naturally found in Garcinia mangostana and Maclura pomifera, and has been shown to exhibit inhibitory activity against protein kinase C.

3542-72-1

Post Buying Request

3542-72-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3542-72-1 Usage

Uses

Used in Pharmaceutical Applications:
Norathyriol is used as a pharmaceutical compound for its inhibitory activity against protein kinase C. This property makes it a potential candidate for the development of drugs targeting various diseases and conditions where protein kinase C plays a significant role.
Used in Natural Product Research:
Norathyriol, being a naturally occurring compound, is also used in the field of natural product research. Its isolation from plants like Garcinia mangostana and Maclura pomifera provides a basis for further investigation into its potential therapeutic applications and the development of novel drugs derived from its structure.
Used in Cancer Research:
Given its inhibitory activity against protein kinase C, norathyriol may also be used in cancer research as a potential anticancer agent. Further studies could explore its effects on various types of cancer and its potential to modulate oncological signaling pathways, similar to the applications of gallotannin in anticancer research.
Used in Drug Delivery Systems:
As with gallotannin, norathyriol could potentially benefit from the development of novel drug delivery systems to enhance its applications and efficacy. Researchers might explore the use of organic and metallic nanoparticles as carriers for norathyriol delivery, aiming to improve its bioavailability and therapeutic outcomes in various medical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 3542-72-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,4 and 2 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 3542-72:
(6*3)+(5*5)+(4*4)+(3*2)+(2*7)+(1*2)=81
81 % 10 = 1
So 3542-72-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H8O6/c14-5-1-9(17)12-11(2-5)19-10-4-8(16)7(15)3-6(10)13(12)18/h1-4,14-17H

3542-72-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name norathyriol

1.2 Other means of identification

Product number -
Other names 2,4,6,7-Tetrahydroxyxanthone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3542-72-1 SDS

3542-72-1Synthetic route

1,3,6,7-tetramethoxy-9H-xanthen-9-one
3542-74-3

1,3,6,7-tetramethoxy-9H-xanthen-9-one

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With hydrogen iodide In various solvent(s) at 160℃; for 8h;94%
With pyridine hydrochloride at 180℃; for 4.5h; Inert atmosphere;85%
With hydrogen bromide In water; acetone for 24h; Reflux; Inert atmosphere;50%
With hydrogen iodide
With pyridine hydrochloride
C21H18O11

C21H18O11

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Stage #1: C21H18O11 With trifluoroacetic anhydride In dichloromethane at 20 - 23℃; for 0.5h; Inert atmosphere;
Stage #2: With boron trifluoride diethyl etherate In dichloromethane at 20 - 23℃; for 2h; Inert atmosphere;
Stage #3: With methanol; potassium carbonate at 20 - 23℃; for 12h; Inert atmosphere;
87%
acide 2,4,6-trihydroxybenzoique
83-30-7

acide 2,4,6-trihydroxybenzoique

benzene-1,2-diol
120-80-9

benzene-1,2-diol

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With zinc(II) chloride; trichlorophosphate at 75℃; for 0.5h; Microwave irradiation;74.1%
mangiferin
4773-96-0

mangiferin

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With hydrogen iodide; phenol for 7h; Heating;43%
With hydrogenchloride; recorcinol In water for 6h; Reagent/catalyst; Reflux;
With hydrogenchloride; recorcinol In water at 150℃; for 6h; Reagent/catalyst; Green chemistry;
maclurin
519-34-6

maclurin

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With culture biomass of Rhodotorula buffonii In aq. phosphate buffer; N,N-dimethyl-formamide for 24h; Time; Microbiological reaction; Heating;25.52%
Stage #1: maclurin With potassium carbonate In water Cooling with ice;
Stage #2: With potassium hexacyanoferrate(III) In water at 20℃; for 5h; Inert atmosphere; Cooling with ice;
25.7%
1,3,6,7-tetrahydroxyxanthone acetate
2054-37-7

1,3,6,7-tetrahydroxyxanthone acetate

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With hydrogenchloride
With sulfuric acid
isomangiferin
24699-16-9

isomangiferin

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With hydrogen iodide; phenol at 150℃; for 5h; labelled comp.;
1,3,7-trihydroxy-6-methoxyxanthone
59092-97-6

1,3,7-trihydroxy-6-methoxyxanthone

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With hydrogen iodide for 2.5h; Heating; labelled comp.; Yield given;
2-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one
906328-94-7

2-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
With hydrogen iodide; phenol at 150℃; for 5h; labelled comp.;
2,4,5-trimethoxybenzoyl chloride
42833-66-9

2,4,5-trimethoxybenzoyl chloride

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) AlCl3, 2.) pyridine, 10percent aq. tetramethylammonium hydroxide / 1.) diethyl ether, RT, 8 h, 2.) reflux, 36 h
2: 94 percent / HI / various solvent(s) / 8 h / 160 °C
View Scheme
Multi-step reaction with 3 steps
1: aluminum (III) chloride / diethyl ether / 48 h / 20 °C
2: pyridine; tetra(n-butyl)ammonium hydroxide / water / 4 h / Reflux
3: pyridine hydrochloride
View Scheme
asaronic acid
490-64-2

asaronic acid

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: oxalyl chloride / benzene / 2 h / Ambient temperature
2: 1.) AlCl3, 2.) pyridine, 10percent aq. tetramethylammonium hydroxide / 1.) diethyl ether, RT, 8 h, 2.) reflux, 36 h
3: 94 percent / HI / various solvent(s) / 8 h / 160 °C
View Scheme
Multi-step reaction with 4 steps
1: thionyl chloride / Reflux
2: aluminum (III) chloride / diethyl ether / 48 h / 20 °C
3: pyridine; tetra(n-butyl)ammonium hydroxide / water / 4 h / Reflux
4: pyridine hydrochloride
View Scheme
Multi-step reaction with 2 steps
1.1: thionyl chloride / dichloromethane / 10 h / Reflux
1.2: 10 h / 0 °C / Reflux
1.3: 12 h / Reflux
2.1: hydrogen bromide / acetone; water / 24 h / Reflux; Inert atmosphere
View Scheme
2,5-dihydroxy-4-methoxybenzoic acid
5981-37-3

2,5-dihydroxy-4-methoxybenzoic acid

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: fused ZnCl2, POCl3 / 2 h / 70 °C
2: HI (d=1.7) / 2.5 h / Heating; labelled comp.
View Scheme
xanthene-1,3,6,7-tetraol
105904-53-8

xanthene-1,3,6,7-tetraol

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
2: chromium (VI)-oxide; acetic acid; acetic acid anhydride
3: concentrated sulfuric acid
View Scheme
Multi-step reaction with 3 steps
2: chromium (VI)-oxide; acetic acid; acetic acid anhydride
3: aq.-ethanolic hydrochloric acid
View Scheme
1,3,6,7-tetraacetoxy-xanthene
102478-32-0

1,3,6,7-tetraacetoxy-xanthene

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: chromium (VI)-oxide; acetic acid; acetic acid anhydride
2: concentrated sulfuric acid
View Scheme
Multi-step reaction with 2 steps
1: chromium (VI)-oxide; acetic acid; acetic acid anhydride
2: aq.-ethanolic hydrochloric acid
View Scheme
2,4,6-trimethoxy-2'-hydroxy-4',5'-dimethoxybenzophenone
42833-68-1

2,4,6-trimethoxy-2'-hydroxy-4',5'-dimethoxybenzophenone

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine; tetra(n-butyl)ammonium hydroxide / water / 4 h / Reflux
2: pyridine hydrochloride
View Scheme
4-methyl-1,2-dihydroxybenzene
452-86-8

4-methyl-1,2-dihydroxybenzene

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: sodium periodate / dichloromethane; water / 1 h / 20 - 23 °C
2.1: N,N'-di-tert-butylethylenediamine; oxygen; copper(l) chloride / dichloromethane / 0.83 h / 20 - 23 °C / 1520.1 Torr
3.1: sodium dithionite / water / 0.5 h / 20 - 23 °C / Inert atmosphere
4.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 4 h / 80 °C / Inert atmosphere
4.2: 12 h / 20 - 23 °C / Inert atmosphere
5.1: sodium dihydrogenphosphate; sodium chlorite / water; dimethyl sulfoxide / 2 h / 20 - 23 °C
6.1: trifluoroacetic anhydride / dichloromethane / 0.5 h / 20 - 23 °C / Inert atmosphere
6.2: 2 h / 20 - 23 °C / Inert atmosphere
6.3: 12 h / 20 - 23 °C / Inert atmosphere
View Scheme
4-methylbenzo-1,2-quinone
3131-54-2

4-methylbenzo-1,2-quinone

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: N,N'-di-tert-butylethylenediamine; oxygen; copper(l) chloride / dichloromethane / 0.83 h / 20 - 23 °C / 1520.1 Torr
2.1: sodium dithionite / water / 0.5 h / 20 - 23 °C / Inert atmosphere
3.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 4 h / 80 °C / Inert atmosphere
3.2: 12 h / 20 - 23 °C / Inert atmosphere
4.1: sodium dihydrogenphosphate; sodium chlorite / water; dimethyl sulfoxide / 2 h / 20 - 23 °C
5.1: trifluoroacetic anhydride / dichloromethane / 0.5 h / 20 - 23 °C / Inert atmosphere
5.2: 2 h / 20 - 23 °C / Inert atmosphere
5.3: 12 h / 20 - 23 °C / Inert atmosphere
View Scheme
5-hydroxy-1,3-phenylene diacetate
116345-96-1

5-hydroxy-1,3-phenylene diacetate

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: N,N'-di-tert-butylethylenediamine; oxygen; copper(l) chloride / dichloromethane / 0.83 h / 20 - 23 °C / 1520.1 Torr
2.1: sodium dithionite / water / 0.5 h / 20 - 23 °C / Inert atmosphere
3.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 4 h / 80 °C / Inert atmosphere
3.2: 12 h / 20 - 23 °C / Inert atmosphere
4.1: sodium dihydrogenphosphate; sodium chlorite / water; dimethyl sulfoxide / 2 h / 20 - 23 °C
5.1: trifluoroacetic anhydride / dichloromethane / 0.5 h / 20 - 23 °C / Inert atmosphere
5.2: 2 h / 20 - 23 °C / Inert atmosphere
5.3: 12 h / 20 - 23 °C / Inert atmosphere
View Scheme
C17H14O7

C17H14O7

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: sodium dithionite / water / 0.5 h / 20 - 23 °C / Inert atmosphere
2.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 4 h / 80 °C / Inert atmosphere
2.2: 12 h / 20 - 23 °C / Inert atmosphere
3.1: sodium dihydrogenphosphate; sodium chlorite / water; dimethyl sulfoxide / 2 h / 20 - 23 °C
4.1: trifluoroacetic anhydride / dichloromethane / 0.5 h / 20 - 23 °C / Inert atmosphere
4.2: 2 h / 20 - 23 °C / Inert atmosphere
4.3: 12 h / 20 - 23 °C / Inert atmosphere
View Scheme
C21H20O9

C21H20O9

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 4 h / 80 °C / Inert atmosphere
1.2: 12 h / 20 - 23 °C / Inert atmosphere
2.1: sodium dihydrogenphosphate; sodium chlorite / water; dimethyl sulfoxide / 2 h / 20 - 23 °C
3.1: trifluoroacetic anhydride / dichloromethane / 0.5 h / 20 - 23 °C / Inert atmosphere
3.2: 2 h / 20 - 23 °C / Inert atmosphere
3.3: 12 h / 20 - 23 °C / Inert atmosphere
View Scheme
C21H18O10

C21H18O10

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium dihydrogenphosphate; sodium chlorite / water; dimethyl sulfoxide / 2 h / 20 - 23 °C
2.1: trifluoroacetic anhydride / dichloromethane / 0.5 h / 20 - 23 °C / Inert atmosphere
2.2: 2 h / 20 - 23 °C / Inert atmosphere
2.3: 12 h / 20 - 23 °C / Inert atmosphere
View Scheme
3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

norathyriol
3542-72-1

norathyriol

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: pyridine / 12 h / 20 - 23 °C
1.2: 24 h / 20 - 23 °C
2.1: N,N'-di-tert-butylethylenediamine; oxygen; copper(l) chloride / dichloromethane / 0.83 h / 20 - 23 °C / 1520.1 Torr
3.1: sodium dithionite / water / 0.5 h / 20 - 23 °C / Inert atmosphere
4.1: dibenzoyl peroxide; N-Bromosuccinimide / tetrachloromethane / 4 h / 80 °C / Inert atmosphere
4.2: 12 h / 20 - 23 °C / Inert atmosphere
5.1: sodium dihydrogenphosphate; sodium chlorite / water; dimethyl sulfoxide / 2 h / 20 - 23 °C
6.1: trifluoroacetic anhydride / dichloromethane / 0.5 h / 20 - 23 °C / Inert atmosphere
6.2: 2 h / 20 - 23 °C / Inert atmosphere
6.3: 12 h / 20 - 23 °C / Inert atmosphere
View Scheme
norathyriol
3542-72-1

norathyriol

chloromethyl methyl ether
107-30-2

chloromethyl methyl ether

1-hydroxy-3,6,7-tris(methoxymethoxy)-9H-xanthen-9-one
1314917-55-9

1-hydroxy-3,6,7-tris(methoxymethoxy)-9H-xanthen-9-one

Conditions
ConditionsYield
Stage #1: norathyriol With N-ethyl-N,N-diisopropylamine In dichloromethane for 0.25h;
Stage #2: chloromethyl methyl ether at 0 - 20℃; for 10h;
81.6%
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 8h; Inert atmosphere;
norathyriol
3542-72-1

norathyriol

benzyl bromide
100-39-0

benzyl bromide

3,6,7-tris(benzyloxy)-1-hydroxy-9H-xanthen-9-one

3,6,7-tris(benzyloxy)-1-hydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 40℃; for 4h;68%
norathyriol
3542-72-1

norathyriol

2-methylbenzyl bromide
89-92-9

2-methylbenzyl bromide

1,6,7-trihydroxy-3-((2-methylbenzyl)oxy)-9H-xanthen-9-one

1,6,7-trihydroxy-3-((2-methylbenzyl)oxy)-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;49.2%
1-bromomethyl-3-methyl-benzene
620-13-3

1-bromomethyl-3-methyl-benzene

norathyriol
3542-72-1

norathyriol

1,6,7-trihydroxy-3-((3-methylbenzyl)oxy)-9H-xanthen-9-one

1,6,7-trihydroxy-3-((3-methylbenzyl)oxy)-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;48.1%
norathyriol
3542-72-1

norathyriol

1-(Bromomethyl)-3-fluorobenzene
456-41-7

1-(Bromomethyl)-3-fluorobenzene

3-((3-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

3-((3-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;44.8%
1-(bromomethyl)-3-chloro-2-fluorobenzene

1-(bromomethyl)-3-chloro-2-fluorobenzene

norathyriol
3542-72-1

norathyriol

3-((3-chloro-2-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

3-((3-chloro-2-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;41.6%
o-fluorobenzyl bromide
446-48-0

o-fluorobenzyl bromide

norathyriol
3542-72-1

norathyriol

3-((2-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

3-((2-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;36.4%
norathyriol
3542-72-1

norathyriol

1-bromomethyl-2-chlorobenzene
611-17-6

1-bromomethyl-2-chlorobenzene

3-((2-chlorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

3-((2-chlorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;35.4%
norathyriol
3542-72-1

norathyriol

4-Fluorobenzyl bromide
459-46-1

4-Fluorobenzyl bromide

3-((4-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

3-((4-fluorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;34.8%
norathyriol
3542-72-1

norathyriol

4-Methylbenzyl bromide
104-81-4

4-Methylbenzyl bromide

1-hydroxy-3,6,7-tris((4-methylbenzyl)oxy)-9H-xanthen-9-one

1-hydroxy-3,6,7-tris((4-methylbenzyl)oxy)-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;33.5%
norathyriol
3542-72-1

norathyriol

4-chlorobenzyl bromide
622-95-7

4-chlorobenzyl bromide

3-((4-chlorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

3-((4-chlorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;32.8%
norathyriol
3542-72-1

norathyriol

1-bromomethyl-3-chlorobenzene
766-80-3

1-bromomethyl-3-chlorobenzene

3-((3-chlorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

3-((3-chlorobenzyl)oxy)-1,6,7-trihydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;32.8%
norathyriol
3542-72-1

norathyriol

4-chlorobenzyl bromide
622-95-7

4-chlorobenzyl bromide

3,6,7-tris((4-chlorobenzyl)oxy)-1-hydroxy-9H-xanthen-9-one

3,6,7-tris((4-chlorobenzyl)oxy)-1-hydroxy-9H-xanthen-9-one

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium iodide at 80℃; for 7h;21.6%
norathyriol
3542-72-1

norathyriol

1-hydroxy-3,6,7-trimethoxyxanthone
2054-36-6

1-hydroxy-3,6,7-trimethoxyxanthone

Conditions
ConditionsYield
With diethyl ether
norathyriol
3542-72-1

norathyriol

acetic anhydride
108-24-7

acetic anhydride

1,3,6,7-tetrahydroxyxanthone acetate
2054-37-7

1,3,6,7-tetrahydroxyxanthone acetate

Conditions
ConditionsYield
With sulfuric acid
With sodium acetate for 2h; Heating; labelled comp.; Yield given;
With pyridine for 24h;
norathyriol
3542-72-1

norathyriol

xanthene-1,3,6,7-tetraol
105904-53-8

xanthene-1,3,6,7-tetraol

Conditions
ConditionsYield
With palladium on activated charcoal; ethanol Hydrogenation;
chlorobromomethane
74-97-5

chlorobromomethane

norathyriol
3542-72-1

norathyriol

1,3-Dihydroxy-6,7-methylenedioxyxanthone
14103-14-1

1,3-Dihydroxy-6,7-methylenedioxyxanthone

Conditions
ConditionsYield
With potassium carbonate 1) acetone, reflux, 1 h, 2) reflux, 16 h; Yield given. Multistep reaction;
norathyriol
3542-72-1

norathyriol

3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

Conditions
ConditionsYield
With potassium hydroxide; sodium hydroxide at 290 - 300℃; for 1h; labelled comp.;

3542-72-1Relevant academic research and scientific papers

Lipid and Phenolic Constituents from Seeds of Hypericum perforatum L. and Hypericum tetrapterum Fr. and their Antioxidant Activity

Heinrich, Miriam,Lorenz, Peter,Daniels, Rolf,Stintzing, Florian C.,Kammerer, Dietmar R.

, (2017)

Seeds of Hypericum perforatum and H. tetrapterum were extracted with dichloromethane and methanol and investigated by chromatographic and mass spectrometric methods. Both species yielded a fatty oil fraction amounting to 30.5% and 18.0% of the seed weight, respectively. Linoleic acid (C18:2n-6) was shown to be the predominant fatty acid constituent. Moreover, xanthone derivatives, i.e. tetrahydroxyxanthones (THX), xanthone-glycosides and xanthone-sulfonates, were assigned in methanolic extracts. For structure elucidation, one representative xanthone, namely 1,3,6,7-THX, was synthesized and analyzed via HPLC-DAD/MSn and GC/MS. Total THX contents were quantitated applying a validated HPLC-DAD method, resulting in 1.25 g/kg (H. perforatum) and 0.27 g/kg (H. tetrapterum), respectively. Moreover, the free radical scavenging capacity of the methanol extracts was tested using the DPPH antioxidant assay. Both, H. perforatum (IC50 = 8.7 mg/l) and 1,3,6,7-THX (IC50 = 3.0 mg/l), exhibited good DPPH free radical scavenging activity compared to Trolox (IC50 = 6.6 mg/l).

A novel and efficient synthesis of norathyriol using Pd(II) as a catalyst

Qin, Qi-Xue,Yang, Jian,Yang, Bo

, p. 1633 - 1636 (2014)

A facile and simple procedure for the synthesis of norathyriol using Pd(II) as a catalyst via two steps under mild conditions is described. The major advantages of this method are the use of a commercially available catalyst, short reaction times, and the simplicity of the reaction and work-up. The overall yield of 36.6 % is acceptable.

XANTHONES FROM THE ROOTS OF Swertia iberica

Denisova, O. A.,Glyzin, V. I.,Patudin, A. V.,Fesenko, D. A.

, p. 145 - 149 (1980)

From the roots of Swertia iberica, together with the previously known swertiaperenin decussatin, gentiakochianin, and norswertianin, we have isolated two new xanthones - isogentiakochianin and swertiaiberin.On the basis of UV, IR, PMR, and mass spectroscopy, the structure of 1,3,8-trihydroxy-7-methoxyxanthone is proposed for isogentiakochianin, and that of 1,2,3-trihydroxy-7,8-dimethoxyxanthone for swertiaiberin.

Yeast-mediated xanthone synthesis through oxidative intramolecular cyclization

Fromentin, Yann,Grellier, Philippe,Buisson, Didier,Lallemand, Marie-Christine,Wansi, Jean Duplex

, p. 5054 - 5057,4 (2012)

Benzoylphloroglucinol derivatives are natural products showing diverse biological activities that could be modulated by structural modifications. For this purpose, we studied the biotransformation of guttiferone A and of maclurin using a combinatorial approach for screening active microorganism strains. We found a novel and unexpected yeast-catalyzed oxidation that has selectively given a new oxy-guttiferone A and norathyriol.

Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors

Jiang, Kaixuan,Gao, Biao,Yu, Jing,Jiang, Lulu,Niu, Ao,Jia, Yihe,Meng, Tao,Zhou, Lu,Wang, Jinxin

supporting information, (2021/02/09)

Phosphoglycerate mutase 1 (PGAM1) is a promising target for cancer treatment. Herein, we found that α-mangostin and γ-mangostin exhibited moderate PGAM1 inhibitory activities, with IC50 of 7.2 μM and 1.2 μM, respectively. Based on α-mangostin, a series of 1,3,6,7-tetrahydroxyxanthone derivatives were designed, synthesized and evaluated in vitro for PGAM1 inhibition. The significant structure–activity relationships (SAR) and a fresh binding mode of this kind of new compounds were also clearly described. This study provides valuable information for further optimization of PGAM1 inhibitors with 1,3,6,7-tetrahydroxyxanthone backbone or de novo design of novel inhibitor.

Preparing method of norathyriol using eco-friendly C-deglycosylation

-

Paragraph 0032-0087, (2019/09/11)

The present invention relates to a method for preparing norathyriol using eco-friendly carbon deglycosylation. The method for preparing norathyriol using eco-friendly carbon deglycosylation comprises: a step of adding mangiferin, resorcinol, or a derivative thereof to a dilute aqueous solution, and heating and refluxing the same; a step of cooling the refluxed solution to room temperature, adding a basic solution, and mixing the mixture; a step of stirring the mixed solution, and then filtering, washing and drying the same; a step of adding the dried crude norathyriol to an organic solvent, and heating and stirring the same; and a step of filtering and washing the stirred solution and concentrating the same. The method in accordance with the present invention is an eco-friendly method which can replace the existing technology which requires the use of toxic materials, and can be used in a mass production method which is needed for research studies of raw materials and medicines using norathyriol.COPYRIGHT KIPO 2019

Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them

Liu, Jie,Zhang, Jianrun,Wang, Huailing,Liu, Zhijun,Zhang, Cao,Jiang, Zhenlei,Chen, Heru

, p. 50 - 61 (2017/04/06)

34 Xanthones were synthesized by microwave assisted technique. Their in?vitro inhibition activities against five cell lines growth were evaluated. The SAR has been thoroughly discussed. 7-Bromo-1,3-dihydroxy-9H-xanthen-9-one (3-1) was confirmed as the most active agent against MDA-MB-231?cell line growth with an IC50 of 0.46?±?0.03?μM. Combination of 3-1 and 5,6-dimethylxanthone-4-acetic acid (DMXAA) showed the best synergistic effect. Apoptosis analysis indicated different contributions of early/late apoptosis and necrosis to cell death for both monomers and the combination. Western Blot implied that the combination regulated p53/MDM2 to a better healthy state. Furthermore, 3-1 and DMXAA arrested more cells on G2/M phase; while the combination arrested more cells on S phase. All the evidences support that the 3-1/DMXAA combination is a better anti-cancer therapy.

A Catalyst-Controlled Aerobic Coupling of ortho-Quinones and Phenols Applied to the Synthesis of Aryl Ethers

Huang, Zheng,Lumb, Jean-Philip

, p. 11543 - 11547 (2016/11/17)

ortho-Quinones are underutilized six-carbon-atom building blocks. We herein describe an approach for controlling their reactivity with copper that gives rise to a catalytic aerobic cross-coupling with phenols. The resulting aryl ethers are generated in high yield across a broad substrate scope under mild conditions. This method represents a unique example where the covalent modification of an ortho-quinone is catalyzed by a transition metal, creating new opportunities for their utilization in synthesis.

Discovery of novel xanthone derivatives as xanthine oxidase inhibitors

Hu, Lina,Hu, Honggang,Wu, Weifeng,Chai, Xiaoyun,Luo, Jianfei,Wu, Qiuye

scheme or table, p. 4013 - 4015 (2011/08/02)

Xanthine oxidase is the key enzyme that catalyzes the oxidation of hypoxanthine to xanthine and then to uric acid. In this study, a series of xanthone derivatives were synthesized as effective and a new class of xanthine oxidase inhibitor. Compounds 8a, 8c, 8i, 8g and 8r showed good inhibition against xanthine oxidase. The presence of a cyano group at the para position of benzyl moiety turned out to be the preferred substitution pattern. Molecular modeling studies were performed to gain an insight into its binding mode with xanthine oxidase, and to provide the basis for further structure-guided design of new non-purine xanthine oxidase inhibitors associated with the xanthone framework.

γ-Pyrone compounds. II: Synthesis and antiplatelet effects of tetraoxygenated xanthones

Lin,Liou,Ko,Teng

, p. 1109 - 1112 (2007/10/02)

Norathyriol and its analogues, 1,3,5,6-, 3,4,5,6-, 3,4,6,7- and 2,3,6,7- tetrahydroxyxanthone, were synthesized from benzophenone precursors by Friedel-Crafts acylation and subsequent base-catalyzed cyclization to eliminate methanol. Both 3,4,6,7- and 2,3,6,7-tetrahydroxyxanthone tetraacetate showed potent anti-platelet aggregation effects on arachidonic acid-induced platelet aggregation. 3,4,6,7-Tetrahydroxyxanthone tetraacetate and 1,3,5,6-tetrahydroxyxanthone showed potent and significant anti-platelet aggregation effects on collagen-induced platelet aggregation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3542-72-1